These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 18408733)

  • 41. Requirement of the coiled-coil domain of PML-RARalpha oncoprotein for localization, sumoylation, and inhibition of monocyte differentiation.
    Kim YE; Kim DY; Lee JM; Kim ST; Han TH; Ahn JH
    Biochem Biophys Res Commun; 2005 May; 330(3):746-54. PubMed ID: 15809060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death.
    Renner F; Moreno R; Schmitz ML
    Mol Cell; 2010 Feb; 37(4):503-15. PubMed ID: 20188669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia.
    Boddy MN; Howe K; Etkin LD; Solomon E; Freemont PS
    Oncogene; 1996 Sep; 13(5):971-82. PubMed ID: 8806687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Curing APL through PML/RARA degradation by As2O3.
    Lallemand-Breitenbach V; Zhu J; Chen Z; de Thé H
    Trends Mol Med; 2012 Jan; 18(1):36-42. PubMed ID: 22056243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
    Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell-cycle regulation and dynamics of cytoplasmic compartments containing the promyelocytic leukemia protein and nucleoporins.
    Jul-Larsen A; Grudic A; Bjerkvig R; Bøe SO
    J Cell Sci; 2009 Apr; 122(Pt 8):1201-10. PubMed ID: 19339552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
    Hirano S; Udagawa O
    Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
    Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.
    Boutell C; Orr A; Everett RD
    J Virol; 2003 Aug; 77(16):8686-94. PubMed ID: 12885887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ability of the human cytomegalovirus IE1 protein to modulate sumoylation of PML correlates with its functional activities in transcriptional regulation and infectivity in cultured fibroblast cells.
    Lee HR; Kim DJ; Lee JM; Choi CY; Ahn BY; Hayward GS; Ahn JH
    J Virol; 2004 Jun; 78(12):6527-42. PubMed ID: 15163746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PML-RARα and its phosphorylation regulate pml oligomerization and HIPK2 stability.
    Shima Y; Honma Y; Kitabayashi I
    Cancer Res; 2013 Jul; 73(14):4278-88. PubMed ID: 23722549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.
    Gao C; Ho CC; Reineke E; Lam M; Cheng X; Stanya KJ; Liu Y; Chakraborty S; Shih HM; Kao HY
    Mol Cell Biol; 2008 Sep; 28(18):5658-67. PubMed ID: 18625722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
    He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
    Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
    Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
    Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
    Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
    J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
    Jing Y; Xia L; Lu M; Waxman S
    Oncogene; 2003 Jun; 22(26):4083-91. PubMed ID: 12821942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Realgar transforming solution-induced differentiation of NB4 cell by the degradation of PML/RARα partially through the ubiquitin-proteasome pathway.
    Hai Y; Wang X; Song P; Li JY; Zhao LH; Xie F; Tan XM; Xie QJ; Yu L; Li Y; Wu ZR; Li HY
    Arch Pharm Res; 2019 Aug; 42(8):684-694. PubMed ID: 31214877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comment on "SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML".
    Ferhi O; Pérès L; Tessier S; de Thé H; Lallemand-Breitenbach V
    Sci Signal; 2016 Aug; 9(440):tc1. PubMed ID: 27507651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.